Literature DB >> 6411817

Resistance of various strains of mycobacteria to killing by activated macrophages in vivo.

I M Orme, F M Collins.   

Abstract

A variety of experimental infections with pathogenic mycobacteria are associated with the development of persistent disease, in which little or no changes in the numbers of the infectious organism can be detected. This report describes a simple experimental model designed to test the hypothesis that this persistence may reflect in part the ability of these organisms to resist the enhanced bacteriostatic and bactericidal properties acquired by host macrophages as a result of these mycobacterial infections. To examine this possibility mice were inoculated with test organisms at a time when these animals were expressing very high levels of nonspecific resistance, and hence macrophage activation, as a result of a prior intravenous infection with Mycobacterium bovis bacillus Calmette-Guerin (BCG). The results show that the test organisms fall into three groups; (a) those, such as Mycobacterium tuberculosis, which were sensitive to the presence of activated macrophages, (b) those, such as Mycobacterium avium and Mycobacterium kansasii, which were insensitive, and (c) one organism, Mycobacterium intracellulare, in which progressive growth of the infection was significantly improved. These results are consistent with the hypothesis that some mycobacteria, particularly those associated with persistent disease, possess an intrinsic resistance to host bactericidal and bacteriostatic mechanisms in vivo.

Entities:  

Mesh:

Year:  1983        PMID: 6411817

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

1.  Intramacrophage growth of Mycobacterium avium during infection of mice.

Authors:  C Frehel; C de Chastellier; C Offredo; P Berche
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

Review 2.  AIDS-related mycobacterial disease.

Authors:  F M Collins
Journal:  Springer Semin Immunopathol       Date:  1988

3.  Natural killer cell-mediated lysis of Mycobacterium-avium complex-infected monocytes.

Authors:  P Katz; H Yeager; G Whalen; M Evans; R P Swartz; J Roecklein
Journal:  J Clin Immunol       Date:  1990-01       Impact factor: 8.317

4.  The role of macrophage activation and of Bcg-encoded macrophage function(s) in the control of Mycobacterium avium infection in mice.

Authors:  R Appelberg; A M Sarmento
Journal:  Clin Exp Immunol       Date:  1990-06       Impact factor: 4.330

Review 5.  Nontuberculous Mycobacteria and Heterologous Immunity to Tuberculosis.

Authors:  Javeed A Shah; Cecilia S Lindestam Arlehamn; David J Horne; Alessandro Sette; Thomas R Hawn
Journal:  J Infect Dis       Date:  2019-08-30       Impact factor: 5.226

6.  T-cell-mediated immunity in persistent Mycobacterium intracellulare infections in mice.

Authors:  T Takashima; F M Collins
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

7.  Efficacy of Mycobacterium bovis BCG vaccination in mice undergoing prior pulmonary infection with atypical mycobacteria.

Authors:  I M Orme; F M Collins
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

8.  Demonstration of acquired resistance in Bcgr inbred mouse strains infected with a low dose of BCG montreal.

Authors:  I M Orme; F M Collins
Journal:  Clin Exp Immunol       Date:  1984-04       Impact factor: 4.330

Review 9.  Infections in patients with inherited defects in phagocytic function.

Authors:  Timothy Andrews; Kathleen E Sullivan
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

10.  Growth of Mycobacterium avium in activated macrophages harvested from inbred mice with differing innate susceptibilities to mycobacterial infection.

Authors:  R W Stokes; F M Collins
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.